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   SIMPLE AND SENSITIVE SPECTROPHOTO-
METRIC ASSAY OF OFLOXACIN IN 
PHARMACEUTICALS BASED ON 
ION-PAIR REACTION 
Two simple, sensitive, economical and extraction-free spectrophotometric me-
thods have been developed for the determination of ofloxacin (OFX) in pure 
form and in tablets. The methods are based on the interaction of OFX with two 
sulphonphthalein dyes, namely, bromothymol blue (method A) and bromophe-
nol blue (method B) in dichloromethane medium to form stable, yellow-colored 
ion–pair complexes peaking at 410 nm. Under the optimum conditions, OFX 
could be assayed in the concentration ranges 1.25-20 and 1.0-16 µg mL
-1 OFX 
by methods A and B, respectively, with correlation coefficient of 0.999 in both 
methods. The apparent molar absorptivity values are calculated to be 1.74×10
4 
and 2.18×10
4, L moL
-1 cm
-1,
 for method A and B, respectively, with correspond-
ing Sandell sensitivity values of 0.021 and 0.017 µg cm
-2. The limits of detec-
tion (LOD) and quantification (LOQ) are also reported. The stoichiometry of the 
reaction was found to be 1:1 in both cases and the conditional stability cons-
tants (Kf) of the complexes have also been reported. The intra-day and inter-
-day variation was assessed. The methods were applied to determine OFX 
from marked tablet formulations. Statistical analysis proved that the proposed 
methods were both accurate and precise. 
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Ofloxacin (OFX), (RS)-7-fluoro-2-methyl-6-(4-me-
thylpiperazine-1-yl)-10-oxo-4-oxa-1-azatricyclo 
[7.3.1.0
5,13]trideca-5(13),6,8,11-tetraene-11-carboxylic 
acid (Figure 1), is a fluoroquinolone antibiotic which 
acts against resistant mutants of bacteria by inhibiting 
DNA gyrase [1]. OFX possesses two relevant ioniz-
able functional groups: a basic piperazinyl group and 
a carboxylic group. The carboxylic group and the car-
bonyl groups are required for antimicrobial activity. 
Fluoroquinolones also affect trace metal metabolism 
and are potent inhibitors of some copper- and zinc- 
-dependent enzymes [2]. OFX is official in the United 
States Pharmacopoeia [3] and the British Pharmaco-
poeia [4], which recommend non-aqueous titrimetry 
[3,4] and HPLC [3] techniques for its assay in bulk 
and dosage forms. 
A survey of the literature revealed that OFX has 
been estimated in pharmaceuticals by atomic absorp-
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tion spectrometry [5], spectrofluorometry [5],
 chemilu-
minescence spectrometry [6-8], stripping voltammetry 
[9], potentiometry and conductometry [10], polarogra-
phy [11], capillary electrophoresis [12,13], HPLC [14- 
-17] and HPTLC [18]. A microbiological assay for OFX 
has also been reported [19]. Many of these techni-
ques are deficient in simplicity, cost-effectiveness and 
easy accessibility. 
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Figure 1. Chemical structure of OFX. 
Spectrophotometry is characterized by its speed 
and simplicity, accuracy and inexpensive instrument 
needed, hence it is an important alternative to other 
analytical techniques with clear advantages in terms 
of cost of analysis. Few UV-spectrophotometric me-P.J. RAMESH et al.: SIMPLE AND SENSITIVE SPECTROPHOTOMETRIC ASSAY OF...  CI&CEQ 16 (4) 353−362 (2010) 
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thods [20-22] have been reported for determination of 
OFX in combined dosage forms. The most widely 
used technique for the assay of OFX has been visible 
spectrophotometry and methods based on diverse re-
action chemistries such as oxidative coupling reaction 
using Ce(IV)-MBTH [23], condensation reaction with 
citric acid-acetic anhydride [24], complex formation 
reaction with Fe (III) nitrate nonahydrate [25], iron (III) 
chloride in HCl medium [26], ion pair complex with 
tropaeolin and supracene violet 3B [27] or with bro-
mophenol blue (BPB), bromothymol blue (BTB) and 
bromocresol purple (BCP) [28] have been reported for 
the determination of OFX. Most of the above visible 
spectrophotometric methods suffer from one or other 
disadvantage such as use of expensive reagents, use 
of heating step, poor sensitivity, liquid-liquid extrac-
tion step and close pH control as indicated in Table 1. 
In the reported extractive spectrophometric 
methods for the determination of OFX
  [27, 28], the 
ion-pairs formed at specific pH were extracted into 
chloroform before measurement. These procedures 
involve strict pH control besides the cumbersome 
extraction step. Many a time, incomplete separation 
may lead to erratic results. In response to the problem 
resulting from extraction of the ion-pair few articles 
were published for the analysis of pharmaceutical 
compounds through ion-pair formation without 
extraction [29-32]. 
In the present study, we explored the utilization 
of a simple ion-pair extraction-free technique for the 
determination of OFX in pure form and in tablets. The 
present methods employed bromothymol blue (BTB) 
and bromophenol blue (BPB) as chromogenic agents 
and the resulting ion pairs are measured directly in 
dichloromethane. The methods were demonstrated to 
be more sensitive than the reported extraction me-
thods [27,28] for OFX and offer the advantages over 
the existing spectrophotometric methods in terms of 
simplicity, sensitivity, speed, accuracy and precision. 
EXPERIMENTAL DETAILS 
Apparatus 
All absorbance measurements were made using 
a Systronics model 106 digital spectrophotometer 
(Ahmedabad, India) equipped with 1-cm matched 
quartz cells. 
Materials and reagents 
All chemicals and reagents used were of ana-
lytical-reagent grade. The solvents used were of 
HPLC-grade. 
Table 1. Comparison of the performance characteristics of the present methods with the published methods 
Sl. No.  Reagents used  Methodology  λmax / nm 
Linear range, µg mL
-1
(ε / L moL
-1 cm
-1) 
Remarks Ref 
1 Ce(IV)-MBTH  Oxidative coupling reaction 
product measured 
640 1-10  Uses expensive reagent, 
less stable species 
measured 
23 
2  Citric acid-acetic 
anhydride 
Pink colored chromogen 
measured 
552  5-55 
(6.04×10
3) 
Boiling for 20 min 
required. 
24 
3 Iron(III)  nitrate  Ambered coloured complex was 
measured 
370  0-62.5 
(A1% = 207) 
Buffers used  25 
4  Iron(III) chloride/HCl  Yellow complex measured  410  20-160  Less sensitive  26 
5  a) Tropaeolin 000 
(TP 000) 
Red chloroform extractable ion-
pair complex measured 
485  2.5-30 
(8.24×10
3) 
Required close pH 
control and involved 
extraction steps 
27 
b) Supracene Violet 
3B (SV 3B) 
Chloroform extractable ion-pair 
complex measured 
575  2.5-25 
(1.09×10
4) 
6 a)  Bromophenol  blue  Yellow chloroform extractable 1:1 
ion-pair complex complex was 
measured 
410  5-25 
(1.04×10
4) 
Required close pH 
control and involved 
extraction steps 
28 
 415  2-15 
(2.01×10
4) 
b) Bromocresol 
purple 
410  2-20 
(1.04×10
4) 
7 a)  Bromothymol  blue 
b) Bromophenol blue 
In both methods, resulting yellow 
colored ion-pair complexes were 
measured 
410  a) 1.25-20 
(1.736×10
4) 
b) 1.0-16 
(2.180×10
4) 
Highly sensitive with 
wide linear dynamic 
ranges, no heating or 
extraction step, no pH-
adjustment, single step 
reaction and inexpensive 
instrumental setup 
Present 
methodsP.J. RAMESH et al.: SIMPLE AND SENSITIVE SPECTROPHOTOMETRIC ASSAY OF...  CI&CEQ 16 (4) 353−362 (2010) 
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– Pharmaceutical grade OFX certified to be 
99.98% pure was received as a gift from Cipla India 
Ltd., Mumbai, India, and was used as received. Stan-
dard OFX solutions were prepared in dichlorome-
thane. 
– Two brands of tablets containing OFX, Zenflox- 
-400 (Mankind Pharma Pvt Ltd., New Delhi, India) 
and Ofloxin-400 (J. B. Chemicals and Pharmaceuti-
cals Ltd, Mumbai, India), used in the investigation 
were purchased from local commercial sources. 
– 0.03% Bromothymol blue (BTB, Loba Chemie, 
Mumbai, India) and 0.05 % bromophenol blue (BPB, 
Loba Chemie, Mumbai, India) were prepared in di-
chloromethane (Merck, Mumbai, India). 
Construction of calibration curves 
Method A 
Aliquots of 0.25, 0.50, 1.0 and 4.0 mL OFX stan-
dard solution in dichloromethane (25 μg mL
-1) were 
measured accurately and transferred into a series of 
5 mL volumetric flasks. 1 mL of 0.03 % BTB was ad-
ded to each flask, diluted to the mark with dichlorome-
thane and mixed well. The absorbance of the result-
ing yellow color chromogen was measured at 410 nm 
against the reagent blank. 
Method B 
Aliquots of 0.25, 0.50, 1.0 and 4.0 mL OFX stan-
dard solution in dichloromethane (20 μg mL
-1) were 
measured accurately and transferred into a series of 
5 mL volumetric flasks. 1 mL of 0.05 % BPB was 
added to each flask, diluted to the mark with dichloro-
methane and mixed well. The absorbance of the re-
sulting yellow color chromogen was measured at 410 
nm against reagent blank. 
In both methods, a standard graph was prepa-
red by plotting the increasing absorbance values ve-
rsus concentration of OFX. The concentration of the 
unknown was read from the standard graph or com-
puted from the respective regression equation derived 
using the Beer’s law data. 
Procedure for the assay of OFX in tablets 
Ten tablets were accurately weighed and pow-
dered. A portion equivalent to 25 mg OFX was ac-
curately weighed and transferred into a 50 mL volu-
metric flask, 30 mL of dichloromethane was added to 
the flask and the content was shaken thoroughly for 
15-20 min to extract the drug into the liquid phase; the 
volume was finally diluted to the mark with dichloro-
methane, mixed well and filtered using a Whatman 
No. 42 filter paper. An aliquot of the filtrate (500 μg 
mL
-1 in OFX) was further diluted to get required con-
centrations and analysed for OFX following the proce-
dures described for the calibration curve. 
Placebo blank analysis 
A placebo blank of commonly employed tablet 
excipients, consisting of talc (10 mg), starch (5 mg), 
acacia (5 mg), methyl cellulose (10 mg), sodium cit-
rate (5 mg), magnesium stearate (10 mg) and sodium 
alginate (5 mg) was made and its solution was pre-
pared as described under ‘Procedure for tablets’, and 
then analysed using the procedures described above. 
Procedure for the determination of OFX in synthetic 
mixture 
To the placebo blank of the composition des-
cribed above, 20 mg of OFX was added and homo-
genized, transferred to a 50 mL volumetric flask and 
the solution was prepared as described under “Proce-
dure for tablets”. An aliquot (10 μg mL
-1 OFX in me-
thod A and 8 µg mL
-1 OFX in method B) was then 
subjected to analysis by the procedures described 
above after appropriate dilution with dichloromethane. 
This analysis was performed to study the interference 
by excipients such as talc, starch, acacia, methyl cel-
lulose, sodium citrate, magnesium stearate and so-
dium alginate. 
Procedure for stoichiometric relationship 
Job’s method of continuous variations of equi-
molar solutions was employed: 6.805×10
-5 M each of 
OFX and BTB (method A) and 5.444×10
-5 M each of 
OFX and BPB (method B) solutions in dichlorome-
thane were prepared separately. A series of solutions 
was prepared in which the total volume of OFX and 
the dye was kept at 5 mL. The drug and reagent were 
mixed in various complementary proportions (0:5, 1:4, 
2:3,…,5:0, inclusive) and completed as directed under 
the recommended procedures. The absorbance of the 
resultant ion-pair complex was measured at 410 nm. 
RESULTS AND DISCUSSION 
OFX is an amino-compound containing a pipera-
zine moiety. Hence, attempts were made to determi-
ne it by applying an ion-pair technique in which basic 
cationic nitrogen in OFX forms an ion-pair with an an-
ionic dye, where a highly yellow colored ion-pair com-
plex is formed. Based on this, two simple methods 
have been developed utilizing BTB and BPB as chro-
mogenic agents. 
Absorption spectra 
OFX in dichloromethane does not absorb in the 
visible region and the new broad absorptions in the P.J. RAMESH et al.: SIMPLE AND SENSITIVE SPECTROPHOTOMETRIC ASSAY OF...  CI&CEQ 16 (4) 353−362 (2010) 
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visible region after the addition of the dyes to the fixed 
concentrations of the drug indicates the formation of 
ion pair complex between the drug and dye. Figure 2 
shows the absorption spectra of the ion-pair complex, 
OFX-dye (BTB and BPB) in dichloromethane. The ab-
sorption maximum of the ion-pair in dichloromethane 
is at 410 nm where the absorbance of the reagent 
blank is insignificant (0.02) in both methods. 
Optimization of reaction conditions 
Optimum reaction conditions for quantitative de-
termination of ion-pair complexes were established via 
various preliminary experiments such as choice of orga-
nic solvent, concentration of the dye and reaction time. 
Choice of organic solvent 
A number of organic solvents such as dichloro-
methane, acetone, methanol, dioxane and carbon tet-
rachloride were examined since OFX is soluble in 
these solvents. Among these solvents, dichlorome-
thane was preferred as the most suitable solvent be-
cause in this medium, the reagent blank gave negli-
gible blank absorbance and the formed ion-pair com-
plex was found to exhibit higher sensitivity and stabi-
lity. In other solvents, the reagent blank yielded high 
absorbance values. 
Effect of dye concentration 
The influence of the concentration of BTB and 
BPB on the intensity of the color developed at the 
selected wavelength and constant drug concentration 
was studied using different amounts (0.25-3.0 mL) of 
0.03% of BTB in method A and (0.25-2.0 mL) of 
0.05% BPB in method B. As shown in Figure 3, the 
constant absorbance readings were obtained bet-
ween (0.5-3.0 mL) of 0.03% of BTB in method A and 
(0.5-2.0 mL) of 0.05% BPB in method B. Hence, 1 mL 
of each 0.03% BTB and 0.05% BPB was used for 
methods A and B, respectively. 
Effect of reaction time 
The optimum reaction time for the development 
of color at ambient temperature (25±2 °C) was studied 
and it was found that complete color development 
was instantaneous in both methods. The formed color 
was stable for at least 60 min in both cases (Figure 4). 
0
0.1
0.2
0.3
0.4
0.5
0.6
360 380 400 420 440 460 480 500 520
Wavelength, nm
A
b
s
o
r
b
a
n
c
e
BTB
BTB (BLANK)
BPB
BPB (BLANK)
 
Figure 2. Absorption spectra of ion-pair complexes (OFX (10 µg mL
-1):BTB (0.03%) and 
OFX (8 µg mL
-1):BPB (0.05%)) against respective reagent blank. 
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Figure 3. Effect of dyes (10 µg mL
-1 OFX in method A and 8 µg mL
-1 OFX in method B). P.J. RAMESH et al.: SIMPLE AND SENSITIVE SPECTROPHOTOMETRIC ASSAY OF...  CI&CEQ 16 (4) 353−362 (2010) 
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Stoichiometric ratio 
In order to establish the molar ratio between OFX 
and dyes, Job’s method of continuous variations was 
applied. In both cases, the plot reached a maximum 
value at a mole fraction of 0.5 which indicated the 
formation of 1:1 (OFX:Dye) complex (Figure 5) bet-
ween positive protonated OFX
+ and BTB
- or BPB
- as 
shown in Scheme 1. In OFX, the nitrogen atom bond-
ed to electron donating methyl group in the piperazine 
ring is the most vulnerable one for protonation [33].  
Conditional stability constants (Kf) of the ion-pair 
complexes 
The conditional stability constants (Kf) of the ion- 
-pair complexes for OFX were calculated from the 
continuous variation data using the following equation 
[34]: 
f
2
mM
m
(1 )( )
nn
A
K
A
A cn
A
+
=
−
 
where A and Am are the observed maximum absor-
bance and the absorbance value when all the drug 
present is associated, respectively. cM is the molar 
concentration of drug at the maximum absorbance 
and n is the stoichiometry with which dye ion asso-
ciates with drug. The log (Kf±CL) (CL – confidence li-
mit at 95 %, n = 3) values for OFX-BTB and OFX-BPB 
ion-pair associates were 7.34±0.56 and 6.78±0.67, 
respectively. 
Method validation procedures 
The proposed methods have been validated for 
linearity, sensitivity, precision, accuracy, selectivity 
and recovery. 
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Figure 4. Effect of time (10 µg mL
-1 OFX in method A & 8 µg mL
-1 OFX in method B). 
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Figure 5. Job’s continuous - variations plots; a) OFX + BTB; b) OFX + BPB. P.J. RAMESH et al.: SIMPLE AND SENSITIVE SPECTROPHOTOMETRIC ASSAY OF...  CI&CEQ 16 (4) 353−362 (2010) 
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Linearity and sensitivity 
Under optimum conditions, a linear relation was 
obtained between absorbance and concentration of 
OFX in the range of 1.25-20.0 μg mL
-1 (method A) 
and 1.0-16.0 μg mL
-1 (method B) (Figure 6). The ca-
libration graph is described by the equation: 
Y = a + bX 
where Y = absorbance, a = intercept, b = slope and X = 
= concentration in µg mL
-1) obtained by the method of 
least squares. Correlation coefficient, intercept and 
slope for the calibration data are summarized in Table 
2. Sensitivity parameters, such as apparent molar ab-
sorptivity and Sandell’s sensitivity values, the limits of 
detection and quantification are calculated as per the 
current ICH guidelines [35] as compiled in Table 2 
speak of the excellent sensitivity of the proposed me-
thods. The limits of detection (LOD) and quantification 
(LOQ) were calculated according to the same guide-
lines using the formulae: 
LOD = 3.3σ/s and LOQ = 10σ/s 
where σ is the standard deviation of five reagent blank 
determinations and s is the slope of the calibration 
curve. 
Precision and accuracy 
In order to evaluate the precision of the pro-
posed methods, solutions containing three different 
concentrations of the OFX were prepared and ana-
lyzed in seven replicates. The analytical results ob-
tained from this investigation are summarized in Tab-
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le 3. The low values of the relative standard deviation 
(%RSD) and percentage relative error (%RE) indicate 
the high precision and the good accuracy of the pro-
posed methods. The percentage relative error calcu-
lated using the following equation: 
Found Taken
%RE= ×100
Taken
− 


 
The assay procedure was repeated seven ti-
mes, and percentage relative standard deviation va-
lues were obtained within the same day to evaluate 
repeatability (intra-day precision) and over five diffe-
rent days to evaluate intermediate precision (inter-day 
precision). 
Selectivity 
The proposed methods were tested for selecti-
vity by placebo blank and synthetic mixture analyses. 
The placebo blank solution prepared as described 
earlier was subjected to analysis according to the re-
commended procedures. The resulting absorbance 
readings for both methods were same as the reagent 
blank, inferring no interference from placebo. 
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Figure 6. Calibration curves; a) OFX + BTB; b) OFX + BPB. 
Table 2. Sensitivity and regression parameters 
Parameter  Method A  Method B 
λmax / nm  410  410 
Linear range, μg mL
-1 1.25-20.0 
  1.0-16.0 
 
Molar absorptivity (ε), L moL
-1 cm
-1  1.736×10
4  2.180×10
4 
Sandell sensitivity
a, μg cm
-2 0.021  0.017 
Limit of detection (LOD), μg mL
-1 0.14  0.08 
Limit of quantification (LOQ), μg mL
-1 0.43  0.23 
Regression equation, Y
b 
Intercept (a)±CL 0.002±0.324  0.0006±0.033 
Slope (b)±CL 0.046±0.0097  0.061±0.002 
Standard deviation of a (Sa) 0.126  0.013 
Standard deviation of b (Sb) 0.007  0.001 
Regression coefficient (r) 0.999 0.999 
a
Limit of determination as the weight in µg per mL of solution, which corresponds to an absorbance of A = 0.001 measured in a cuvette of cross-sectional 
area 1 cm
2 and l = 1 cm; 
b
Y = a + bX, Where Y is the absorbance, X is concentration in μg mL
-1
, a is intercept, b is slope. CL is confidence limit at 95% 
Table 3. Evaluation of intra-day and inter-day accuracy and precision 
Method
  OFX taken 
µg mL
-1 
Intra-day accuracy and precision (n = 7) Inter-day accuracy and precision (n = 7) 
OFX found±CL, μg mL
-1 %RE %RSD OFX  found±CL,  μg mL
-1 %RE  %RSD 
Method A  10.0  9.78±0.099  2.21  1.02  9.70±0.156  3.00  1.18 
15.0 14.81±0.156  1.27  1.14  14.61±0.174  2.61  1.29 
20.0 19.42±0.219  2.89  1.22  19.38±0.235  3.10  1.31 
Method B  4.0  3.92±0.043  2.00  1.17  3.88±0.044  3.00  1.24 
8.0 7.83±0.075  2.12  1.04  7.78±0.081  2.75  1.13 
12.0 11.73±0.131  2.25  1.21  11.7±0.139  2.50  1.29 P.J. RAMESH et al.: SIMPLE AND SENSITIVE SPECTROPHOTOMETRIC ASSAY OF...  CI&CEQ 16 (4) 353−362 (2010) 
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A separate experiment was performed with the 
synthetic mixture. The analysis of synthetic mixture 
solution prepared above yielded percent recoveries 
which ranged of 98.45-103.6 with standard deviation 
of 0.91–1.13 in all the cases. The results of this study 
are presented in Table 4 indicating that the inactive 
ingredients did not interfere in the assay. These re-
sults further demonstrate the accuracy as well as the 
precision of the proposed methods. 
Application to formulations 
In order to evaluate the analytical applicability of 
the proposed methods to the quantification of OFX in 
commercial tablets, the results obtained by the pro-
posed methods were compared to those of the refe-
rence method [4] by applying Student’s t-test for ac-
curacy and F-test for precision. The reference method 
involved the titration of OFX in anhydrous acetic acid 
with acetous perchloric acid to a potentiometric end 
point detection. The results (Table 5) show that the 
Student’s t- and F-values at 95 % confidence level are 
less than the tabulated values, which confirmed that 
there is good agreement between the results obtained 
by the proposed methods and the reference method 
with respect to accuracy and precision. 
Recovery studies 
The accuracy and validity of the proposed me-
thods were further ascertained by performing reco-
very studies. Pre-analysed tablet powder was spiked 
with pure OFX at three concentration levels (50, 100 
and 150% of that in tablet powder) and the total was 
found by the proposed methods. In all cases, the ad-
ded OFX recovery percentage values ranged of 98.60- 
-102.9% with standard deviation of 1.07-1.21 (Table 
6) indicating that the recovery was good, and that the 
co-formulated substance did not interfere in the deter-
mination. 
Table 4. Recovery of the drug from synthetic mixture 
Method  OFX in syntheticmixture taken, μg mL
-1 OFX  recoverd
a±SD, % 
Method A  10.0 102.8±1.04 
15.0 98.45±0.91 
20.0 102.7±0.99 
Method B  4.0 103.6±1.00 
8.0 100.9±1.07 
12.0 102.5±1.13 
a
Mean value of five determinations 
Table 5. Results of analysis of tablets by the proposed methods 
Tablet Brand name
  Label claim, mg/tablet
  Found
a±SD, % of label claim
 
Reference method
  Method A
  Method B
 
Zenflox-400
b 20  99.92±1.11  98.12±1.19 
t = 2.47 
F = 1.15 
98.87±1.15 
t = 1.47 
F = 1.07 
Ofloxin-400
c 20  100.3±1.06  98.95±1.12 
t = 1.96 
F = 1.12 
102.1±1.17 
t = 2.55 
F = 1.21 
a
Mean value of five determinations; 
b
Mankind Pharma Pvt Ltd., New Delhi, India; 
c
J. B. Chemicals and Pharmaceuticals Ltd., Mumbai, India. The value of t
(tabulated) at 95% confidence level and for four degrees of freedom is 2.77. The value of F (tabulated) at 95% confidence level and for four degrees of 
freedom is 6.39 
Table 6. Accuracy assessment by recovery experiments 
Method  Tablet studied  OFX in tablet, μg mL
-1 Pure  OFX  added,  μg mL
-1 Total found±SD, μg mL
-1 Pure  OFX  recovered
a±CL, %
Method A  Ofloxin-400  5.0  2.5  7.48± 1.14  99.20 ±  2.832 
5.0  5.0  9.93± 1.07  98.60 ±  2.658 
5.0  7.5  12.45± 1.11  99.33 ± 2.758 
Method B  Ofloxin-400  4.0  2.0  6.02± 1.17  101.0 ± 2.907 
4.0  4.0  8.12± 1.09  102.9 ± 2.708 
4.0  6.0  9.97± 1.21  99.50 ± 3.006 
a
Mean value of three measurements. CL is confidence limit at 95% P.J. RAMESH et al.: SIMPLE AND SENSITIVE SPECTROPHOTOMETRIC ASSAY OF...  CI&CEQ 16 (4) 353−362 (2010) 
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CONCLUSIONS 
Two simple, fast, extraction-free spectrophoto-
metric methods for the determination of OFX in pure 
form and in tablets were developed and validated as 
per as the current ICH guidelines. Compared with most 
of the existing methods for OFX, the present methods 
are very simple, rapid and cost effective. Of the non- 
-chromatographic methods, the method based on ato-
mic absorption spectrophotometry [5] requires an ex-
pensive instrument. Although chemiluminescence me-
thods [6-8] are sensitive, they require expensive ex-
perimental set up. The differential pulse voltammetric 
method [9] also requires strict pH control and is less 
sensitive (linear range 10-100 μg mL
-1). The chroma-
tographic methods [10-14], no doubt, are sensitive 
and selective; however require complex and expen-
sive equipment, provision for use and disposal of large 
quantities solvents, labour-intensive sample prepara-
tion procedure and personnel skilled in chromatogra-
phic techniques. 
The reported visible spectrophotometric me-
thods based on oxidative-coupling reaction [23] uses 
expensive reagent and the reaction product is less 
stable. The method based on condensation reaction 
[24] involves boiling step for 20 min. Complexation re-
action procedures suffer from strict pH control [25] 
less sensitive (linear range 20-160 μg mL
-1) [26]. Ex-
tractive-spectrophotometric methods [27,28] based on 
ion-pair complex formation reactions, though sensi-
tive and selective, are devoid of simplicity since criti-
cal pH control and liquid-liquid extraction step are in-
volved.  
In contrast to the above published visible spec-
trophotometric methods [23-28], the proposed extrac-
tion free spectrophotometric methods based on ion- 
-pair complex formation reactions require only dyes 
as reagents which are cheaper and readily available, 
can be applied at ambient temperature, color deve-
lopment is instantaneous and neither involves strict 
pH adjustment nor complicated extraction step. The 
proposed methods have wide linear dynamic ranges 
and are most sensitive than most of other published 
methods. They can be useful in quality control and 
routine analysis of OFX in pharmaceuticals since both 
methods are simple, accurate and free from common 
additives and excipients that might be found in com-
mercial preparations. 
Acknowledgements 
The authors wish to acknowledge Cipla India 
Ltd., Mumbai, India, for providing the gift sample of 
ofloxacin. Three of the authors (PJR, OZD and KBV) 
thank the authorities of the University of Mysore for 
kind permission and facilities to carry out the research 
work. 
REFERENCES 
[1]  A. Goodman, L. S. Goodman, T. W. Hall, F. Murad, Las 
Bases Farmacologicas  de la Terapeutica, Madrid, 1989 
1132-1136 
[2]  V. Kapetanovic, L. Milavanovic, M. Ereeg, Talanta 43 
(1996) 2123-2130 
[3]  United States Pharmacopoeia, National Formulary XVII, 
Rockville, USA Convention, 22 (1990) 912 
[4]  British Pharmacopeia, Her Majesty’s Stationery office, 
London, 3 (2003) 1357 
[5]  H. Salem, Am. J. Appl. Sci. 2 (2005) 719-729 
[6]  P. Francis, J. L. Adcock, Anal. Chim. Acta 541 (2005) 3-12 
[7]  H. Sun, L. Li, X. Chen, Anal. Sci 22 (2006) 1145-1149 
[8]  J. Murillo, M. Alanon, I. Munaz, I. M. Duran, G. A. Jime-
nez, J. Fuoresc. 17 (2007) 481-91 
[9]  M. Tamer, Anal. Chim. Acta 231 (1990)129-131 
[10]  M. Tuncel, Z. Atkosar, Pharmazie 47 (1992) 642-653 
[11]  G. Zhou, J. Pan, Anal. Chim. Acta 307 (1995) 49-53 
[12]  A.E. Abdalla, S. Bahruddin, S.M. I. Abdussalam, I.S. 
Muhammad, Y.A. Hassan, J. Liq. Chromatogr. Rel. 
Technol. 31 (2008) 348-360 
[13]  S.W. Sun, A.L. Wu, J. Liq. Chromatogr. Rel. Technol. 22 
(1999) 281-296 
[14]  A.P. Arjekar, U.S. Kapadia, S.V. Raj, S.S. Kunjir, Indian 
drugs 33 (1996) 261-266 
[15]  G. Carlucci, P. Mazzeo, T. Fantozzi, Anal. Lett. 26 (1993) 
2193-2201 
[16]  R.R. Kalta, R. Sharma, S.C. Chaturvedi, Indian J. Pharm. 
Sci. 70 (2008) 491-494 
[17]  V.M. Shinde, B.S. Desai, N.M. Tendolkar, Indian Drugs 
35 (1998) 715-717 
[18]  P. Srividya, R.M. Cardoza, P.D. Amin, Indian Drugs 40 
(2003) 41-43 
[19]  E.V.L. Silveria, E.E.S. Schapoval, J. Pharm. Biomed. 
Anal. 1-2 (2002) 91-96 
[20]  D.F. Jitendra, P.M. Harshal, Y.C. Rajesh, R.P. Vijay, Int. 
J. Chem. Tech. Research 1 (2009) 189-194 
[21]  K.P. Bhusari, D.R. Chaple, Asian J. Research Chem. 2 
(2009) 60-62 
[22]  P.D. Panzade, K.R. Mahadik, Indian Drugs 38 (2001) 
368-370 
[23]  C.S.P. Sastry, K. Rama Rao, D. Siva Prasad, Indian 
Drugs 32 (1995) 172 
[24]  P.U. Patel, B.N. Suhagia, M.M. Patel, Indian Pharmacist 
6 (2007) 59 
[25]  J.E. Chukwuenweniwe, O.A. Solomon, O.A. John, J. 
Antimicrobial Chemotherapy 39 (1997) 639-641 
[26]  S.C. Mathur, Y. Kumar, N. Murugesan, Indian Drugs 29 
(1992) 376 
[27]  C.S.P. Sastry, K. Rama Rao, D. Siva Prasad, Talanta 42 
(1995) 311 P.J. RAMESH et al.: SIMPLE AND SENSITIVE SPECTROPHOTOMETRIC ASSAY OF...  CI&CEQ 16 (4) 353−362 (2010) 
 
362 
[28]  Y.M. Issa, F.M. Abdel-Gawad, M.A. Abou Table, Anal. 
Lett .30 (1997) 2071 
[29]  H. Abdine, F. Belal, N. Zoman, II Farmaco 57 (2002) 267- 
–271 
[30]  S.M. Al-Ghannam, J. Pharm. Biomed. Anal. 40 (2006) 
151-156 
[31]  P. Shahdousti, M. Aghamohammadi, N. Alizadeh, Spec-
trochim. Acta A 69 (2008) 1195-1200 
[32]  D.H. Manjunatha, S.M.T. Shaikh, K. Harikrishna, R. 
Sudhirkumar, P.B. Kandagal, J. Seetharamappa, Eclet. 
Quim. 33 (2008) 37-40 
[33]  K. Harikrishna, B.S. Nagaralli, J. Seetharamappa, J. Food 
Drug Anal. 16 (2008) 11-17 
[34]  A.S. Amin, A.A. El-Fetouh, R. Gouda, F.Z. El-Sheikh, 
Spectrochim. Acta A 67 (2007) 1306 
[35]  International Conference on Harmonisation of Technical 
Requirements for Registration of Pharmaceuticals for Hu-
man Use, Ich Harmonised Tripartite Guideline, Validation 
of Analytical Procedures: Text and Methodology, Q2 (R 
1), Complementary Guideline on Methodology, dated 06 
November 1996, London, incorporated in November 
2005. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P.J. RAMESH 
K. BASAVAIAH 
O. ZENITA DEVI 
K.B. VINAY 
Department of Chemistry, 
University of Mysore, Manasa-
gangotri, Mysore-570006, India 
NAUČNI RAD 
   JEDNOSTAVNA I OSETLJIVA SPEKTROFOTO-
METRIJSKA METODA ZA ODREĐIVANJE OFLOKSA-
CINA U FARMACEUTSKIM PREPARATIMA ZASNO-
VANA NA REAKCIJI FORMIRANJA JONSKOG PARA 
Razvijene su dve jednostavne, osetljive i ekonomične spektrofotometrijske metode za 
određivanje oflaksacina (OFX) u čistoj formi i u tabletama, bez primene ekstrakcije. Me-
tode se zasnivaju na interakciji OFX sa dve sulfonftaleinske boje, bromtimol plavo (me-
toda A) i bromfenol plavo (metoda B) u dihlormetanu, pri čemu se grade stabilni žuto 
obojeni jon-par kompleksi sa maksimumima apsorpcije na 410 nm. Pod ovim optimalnim 
uslovima OFX može biti određen po metodi A u koncentracijskom opsegu 1,25-20 μg/ml, a 
po metodi B u koncentracijskom opsegu 1,0-16 μg/ml, sa koeficijentom korelacije od 
0,999 za obe metode. Molarna apsorptivnost kompleksa iznosi 1,74×10
4 L mol
-1 cm
-1 za 
metodu A i 2,18×10
4 L mol
-1 cm
-1 za metodu B, a odgovarajući Sandelovi indeksi su 
0,021 i 0,017 μg cm
-2. Takođe su određeni limiti detekcije i kvantifikacije. U oba slučaja 
reakcija se odvija u stehiometrijskom odnosu 1:1. Izračunate su konstante stabilnosti 
kompleksa i varijacije u za određene vremeske periode u toku dana i za više dana. Sta-
tistička analiza je pokazala da su predložene motode tačne i precizne i da se mogu pri-
menjivati za određivanje OFX u tabletama. 
Ključne reči: određivanje; sulfonftaleinske boje; reakcije formiranja jonskog para. 
 
 